Avraham Raz
Biography
Avraham Raz is a Professor (Research Educator) in the department of Oncology.
Office Address
421 E. Canfield
Detroit, Michigan, 48201
Education/Training
Ph.D. (with distinction) The Weizmann Institute of Science, Department of Membrane Research. Rehovot, Israel. Thesis; “Structural and Functional Changes in Cells and Membranes in Response to Drugs and Concanavalin A” 1978
M. Sc. (with distinction) in Physiology, Ben-Gurion University of the Negev, and the Hebrew University of Jerusalem, Israel 1972
B.Sc. (with distinction) in Biology, Ben-Gurion University of the Negev, Beer-Sheva, Israel 1970
POST GRADUATE TRAINING:
Research Fellow, the Department of Cell Biology. The Weizmann Institute of Science, Rehovot, Israel 1980-1981
Postdoctoral Fellowship at the National Cancer Institutes, Bethesda, MD 1978-1981
Office Phone
313-578-4330
Honors and Awards
ScholarGPS Team: placed you in the top 0.05% of all scholars worldwide, 2024
Wayne State University; Academy of Scholar, 2023
Multiple National and International awards Including; NCI/NIH&MERIT Awards;, (The First Awardee from the State of Michigan)
Research
Cancer, metastases, motility and carbohydrate recognition
Publications
Publications
- Nangia-Makker P, Shekhar MPV, Hogan V, Balan V, Raz A. (2022) MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis. Oncotarget. 13:534-550.
- Zhao Z, Xu X, Cheng H, Miller MC, He Z, Gu H, Zhang Z, Raz A, Mayo KH, Tai G, Zhou Y. (2021) Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separation. Proc. Natl Acad Sci U S A.;118(19): e202107411.
- Nakajima K, Raz A. (2020) Autocrine motility factor and its receptor expression in musculoskeletal tumors. J Bone Oncol. 4:100318
- Nakajima K, Raz A. (2021) T-cell infiltration profile in musculoskeletal tumors. J Orthop Res.39(3):536-54
- Nakajima K, Raz A. (2020) Amplification of autocrine motility factor and its receptor in multiple myeloma and other musculoskeletal tumors. J Bone Oncol.;23:100308
Review Articles
- Nangia-Makker P, Hogan V, Balan V, Raz A. (2022) Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases. J Biol Chem. 2022 Dec;298(12):102622.
- Pedrosa LF, Raz A, Fabi JP. (2022) The Complex Biological Effects of Pectin: Galectin-3 Targeting as Po-tential Human Health Improvement? Biomolecules.12(2):289.
- Nakajima K, Balan V, Raz A. (2021) Galectin-3: an immune checkpoint target for musculoskeletal tumor patients. Cancer Metastasis Rev. 40(1):297-302
- Eliaz I, Raz A. (2019) Pleiotropic Effects of Modified Citrus Pectin. Nutrients.;11(11):2619
Editorial
- Raz A, Crissman JC, Volpe C. (2023). Kenneth V. Honn, Ph.D. (1946-2023) Cancer Metastasis Rev. 42(2):589-590.